We are live on ! Find out more
NXTC icon

NextCure
NXTC

45 hedge funds and large institutions have $13.1M invested in NextCure in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

5% more funds holding

Funds holding: 43 → 45 (+2)

0.05% more ownership

Funds ownership: 4.73% → 4.77% (+0.05%)

40% less capital invested

Capital invested by funds: $21.7M → $13.1M (-$8.6M)

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$1.7M
2
Renaissance Technologies
Renaissance Technologies
New York
+$139K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$59.1K
4
TCM
Tang Capital Management
California
+$58.4K
5
VCIM
Velan Capital Investment Management
Georgia
+$30.6K

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$3.42M
2
AI
Acuitas Investments
Washington
-$469K
3
LFCM
Long Focus Capital Management
Puerto Rico
-$454K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$117K
5
Millennium Management
Millennium Management
New York
-$36.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$2.06M – – –
P
2
Pfizer
New York
$1.89M +$1.79M +121,546 New
AAA
3
Affinity Asset Advisors
New York
$1.78M – – –
Citigroup
4
Citigroup
New York
$1.07M +$1.7M +115,753 New
O
5
OrbiMed
New York
$880K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$761K – – –
BlackRock
7
BlackRock
New York
$561K -$2.77K -188 -0.3%
TCM
8
Tang Capital Management
California
$540K +$58.4K +3,967 +7%
CCC
9
Cable Car Capital
California
$475K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$400K +$139K +9,442 +28%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$375K – – –
PLC
12
Peapod Lane Capital
New York
$311K +$495K +33,642 New
Federated Hermes
13
Federated Hermes
Pennsylvania
$243K -$7.78K -529 -2%
BCM
14
BML Capital Management
Indiana
$211K -$3.59K -244 -1%
CPA
15
Cardiff Park Advisors
California
$202K – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$180K +$12.5K +848 +5%
LFCM
17
Long Focus Capital Management
Puerto Rico
$143K -$454K -30,847 -67%
Macquarie Group
18
Macquarie Group
Australia
$116K – – –
SCM
19
Sio Capital Management
New York
$100K – – –
ACM
20
ADAR1 Capital Management
Texas
$92.5K – – –
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
$83K – – –
AC
22
Armistice Capital
New York
$80.2K +$4.91K +334 +4%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$66.2K – – –
Citadel Advisors
24
Citadel Advisors
Florida
$60.7K +$27.9K +1,894 +41%
BCM
25
Bridgeway Capital Management
Texas
$52.1K -$3.68K -250 -4%
1
2 3

NXTC Hedge Fund Activity: Q4 2024 in Review

45 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2024, worth a combined $13.1M — down 40% from $21.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NXTC positions and 6 closed out — a net gain of 2 holders — while 6 added to existing stakes and 11 trimmed.

The largest buyer was Citigroup, opening a new position worth an estimated $1.7M. The largest seller was Logos Global Management, exiting entirely with an estimated $3.42M sold.

  • 45 institutional investors held NextCure (NXTC) as of Q4 2024, up from 43 in Q3 2024.
  • Funds reported $13.1M of NextCure stock for Q4 2024, down 40% quarter-over-quarter.
  • 8 funds opened new NextCure positions in Q4 2024 and 6 closed out, a net change of +2 holders.
  • The largest NextCure buyer in Q4 2024 was Citigroup, an estimated $1.7M added.
  • The largest NextCure seller in Q4 2024 was Logos Global Management, an estimated $3.42M sold.

Based on aggregated 13F filings for Q4 2024.